Advertisement
Australia markets closed
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • AUD/USD

    0.6449
    -0.0003 (-0.04%)
     
  • ASX 200

    7,683.50
    +34.30 (+0.45%)
     
  • OIL

    83.02
    +0.17 (+0.21%)
     
  • GOLD

    2,315.50
    -30.90 (-1.32%)
     
  • Bitcoin AUD

    103,007.44
    +38.74 (+0.04%)
     
  • CMC Crypto 200

    1,402.16
    -12.60 (-0.89%)
     

American Shared Hospital Services Announces Fourth Quarter and Year End 2022 Earnings Conference Call

American Shared Hospital Services
American Shared Hospital Services

Conference Call on Friday March 24th, 2023 at 1:00 pm ET / 10:00 am PT

SAN FRANCISCO, CA, March 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a quarterly conference call to discuss its fourth quarter and year end 2022 financial results on Friday March 24th, 2023 at 1:00 pm ET / 10:00 am PT. The fourth quarter and year end 2022 financial results press release will be issued before the market open on Friday March 24th, 2023.

Teleconference Date/Time

Friday March 24th, 2023 at 1:00 pm ET / 10:00 am PT

ADVERTISEMENT

Teleconference and Webcast Information

To participate, please call 1 (844) 413-3972 at least 10 minutes prior to the start of the call and ask to join the American Shared Hospital Services call.

A simultaneous webcast of the call may be accessed through the Company's website, www.ashs.com, or at www.streetevents.com for institutional investors.

A replay of the call will be available at 1 (877) 344-7529, access code 7388246, through March 31, 2023. The call will also be available for replay on the Company’s website, www.ashs.com, for one year.

About American Shared Hospital Services (NYSE American: AMS)

American Shared Hospital Services is a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. AMS is a world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations, and trigeminal neuralgia (facial pain). The Company also offers proton therapy, and the latest IGRT, IMRT and MR/LINAC systems. For more information, please visit: www.ashs.com.

Contacts:
American Shared Hospital Services
Ray Stachowiak
Executive Chairman
rstachowiak@ashs.com

Investor Relations
PCG Advisory
Stephanie Prince
(646) 863-6341
sprince@pcgadvisory.com